ACAD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Acadia Pharmaceuticals Inc (ACAD).


$3.05B Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

ACAD Market Cap. (MRY)


ACAD Shares Outstanding (MRY)


ACAD Assets (MRY)


Total Assets

$1.19B

Total Liabilities

$454.96M

Total Investments

$436.40M

ACAD Income (MRY)


Revenue

$957.80M

Net Income

$226.45M

Operating Expense

$645.16M

ACAD Cash Flow (MRY)


CF Operations

$157.72M

CF Investing

-$30.54M

CF Financing

$6.84M

ACAD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ACAD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,187,756,000 (58.59%)

$748,956,000 (27.41%)

$587,812,000 (-16.04%)

$700,122,000 (-10.54%)

Assets Current

$938,318,000 (52.29%)

$616,125,000 (21.30%)

$507,937,000 (-17.79%)

$617,823,000 (-13.91%)

Assets Non-Current

$249,438,000 (87.79%)

$132,831,000 (66.30%)

$79,875,000 (-2.95%)

$82,299,000 (26.61%)

Goodwill & Intangible Assets

$119,782,000 (82.90%)

$65,490,000 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$732,793,000 (69.72%)

$431,755,000 (7.83%)

$400,413,000 (-25.97%)

$540,894,000 (-13.73%)

Property Plant & Equipment Net

$50,786,000 (-10.06%)

$56,467,000 (-8.32%)

$61,594,000 (-7.12%)

$66,315,000 (17.49%)

Cash & Equivalents

$328,359,000 (68.89%)

$194,427,000 (61.20%)

$120,616,000 (-21.27%)

$153,205,000 (-53.83%)

Accumulated Other Comprehensive Income

$292,000 (1116.67%)

$24,000 (102.46%)

-$975,000 (-407.81%)

-$192,000 (-633.33%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$436,404,000 (74.42%)

$250,208,000 (-17.14%)

$301,977,000 (-19.10%)

$373,271,000 (22.01%)

Investments Current

$436,404,000 (74.42%)

$250,208,000 (-17.14%)

$301,977,000 (-19.10%)

$373,271,000 (22.01%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$91,690,000 (126.69%)

$40,447,000 (249.89%)

$11,560,000 (-18.00%)

$14,098,000 (45.61%)

Trade & Non-Trade Receivables

$104,695,000 (2.29%)

$102,350,000 (62.25%)

$63,080,000 (-3.46%)

$65,344,000 (29.96%)

Trade & Non-Trade Payables

$16,192,000 (-7.70%)

$17,543,000 (37.64%)

$12,746,000 (85.37%)

$6,876,000 (-19.04%)

Accumulated Retained Earnings (Deficit)

-$2,204,386,000 (9.32%)

-$2,430,837,000 (-2.59%)

-$2,369,551,000 (-10.03%)

-$2,153,576,000 (-8.45%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$42,037,000 (-12.06%)

$47,800,000 (-9.29%)

$52,695,000 (-6.11%)

$56,126,000 (26.24%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$42,037,000 (-12.06%)

$47,800,000 (-9.29%)

$52,695,000 (-6.11%)

$56,126,000 (26.24%)

Total Liabilities

$454,963,000 (43.43%)

$317,201,000 (69.27%)

$187,399,000 (17.69%)

$159,228,000 (2.33%)

Liabilities Current

$394,870,000 (55.31%)

$254,254,000 (102.38%)

$125,630,000 (30.77%)

$96,068,000 (-9.34%)

Liabilities Non-Current

$60,093,000 (-4.53%)

$62,947,000 (1.91%)

$61,769,000 (-2.20%)

$63,160,000 (27.24%)

ACAD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$957,797,000 (31.85%)

$726,437,000 (40.45%)

$517,235,000 (6.83%)

$484,145,000 (9.60%)

Cost of Revenue

$81,841,000 (96.55%)

$41,638,000 (309.58%)

$10,166,000 (-6.24%)

$10,843,000 (6.19%)

Selling General & Administrative Expense

$488,428,000 (20.14%)

$406,559,000 (10.15%)

$369,090,000 (-6.80%)

$396,028,000 (1.90%)

Research & Development Expense

$303,249,000 (-13.76%)

$351,619,000 (-2.75%)

$361,575,000 (51.02%)

$239,415,000 (-24.98%)

Operating Expenses

$645,162,000 (-14.91%)

$758,178,000 (3.77%)

$730,665,000 (13.50%)

$643,741,000 (-10.36%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$31,624,000 (208.53%)

$10,250,000 (304.98%)

$2,531,000 (621.08%)

$351,000 (-42.55%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$226,451,000 (469.50%)

-$61,286,000 (71.62%)

-$215,975,000 (-28.66%)

-$167,870,000 (40.38%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$226,451,000 (469.50%)

-$61,286,000 (71.62%)

-$215,975,000 (-28.66%)

-$167,870,000 (40.38%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$226,451,000 (469.50%)

-$61,286,000 (71.62%)

-$215,975,000 (-28.66%)

-$167,870,000 (40.38%)

Weighted Average Shares

$165,717,000 (1.16%)

$163,819,000 (1.32%)

$161,683,000 (0.74%)

$160,493,000 (2.01%)

Weighted Average Shares Diluted

$166,362,000 (1.55%)

$163,819,000 (1.32%)

$161,683,000 (0.74%)

$160,493,000 (2.01%)

Earning Before Interest & Taxes (EBIT)

$258,075,000 (605.67%)

-$51,036,000 (76.09%)

-$213,444,000 (-27.41%)

-$167,519,000 (40.38%)

Gross Profit

$875,956,000 (27.91%)

$684,799,000 (35.05%)

$507,069,000 (7.13%)

$473,302,000 (9.68%)

Operating Income

$230,794,000 (414.52%)

-$73,379,000 (67.18%)

-$223,596,000 (-31.19%)

-$170,439,000 (40.53%)

ACAD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$30,538,000 (-195.44%)

$31,998,000 (-56.31%)

$73,241,000 (203.01%)

-$71,102,000 (-136.93%)

Net Cash Flow from Financing

$6,845,000 (-72.76%)

$25,129,000 (206.49%)

$8,199,000 (-54.86%)

$18,162,000 (-77.58%)

Net Cash Flow from Operations

$157,719,000 (844.31%)

$16,702,000 (114.65%)

-$114,035,000 (9.25%)

-$125,660,000 (7.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

$133,932,000 (81.45%)

$73,811,000 (326.49%)

-$32,589,000 (81.75%)

-$178,593,000 (-230.05%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$30,015,000 (-141.66%)

$72,048,000 (-1.63%)

$73,241,000 (204.66%)

-$69,980,000 (-134.97%)

Capital Expenditure

-$523,000 (-946.00%)

-$50,000 (0%)

$0 (0%)

-$1,122,000 (85.21%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$6,845,000 (-72.76%)

$25,129,000 (206.49%)

$8,199,000 (-54.86%)

$18,162,000 (-77.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$94,000 (-422.22%)

-$18,000 (-400.00%)

$6,000 (-14.29%)

$7,000 (187.50%)

Share Based Compensation

$67,049,000 (0.95%)

$66,421,000 (-2.61%)

$68,201,000 (7.21%)

$63,615,000 (-24.65%)

Depreciation Amortization & Accretion

$15,883,000 (186.08%)

$5,552,000 (174.04%)

$2,026,000 (-39.41%)

$3,344,000 (14.05%)

ACAD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

91.50% (-2.97%)

94.30% (-3.78%)

98.00% (0.20%)

97.80% (0.10%)

Profit Margin

23.60% (380.95%)

-8.40% (79.90%)

-41.80% (-20.46%)

-34.70% (45.53%)

EBITDA Margin

28.60% (553.97%)

-6.30% (84.60%)

-40.90% (-20.65%)

-33.90% (46.10%)

Return on Average Equity (ROAE)

39.50% (351.59%)

-15.70% (68.97%)

-50.60% (-69.80%)

-29.80% (31.65%)

Return on Average Assets (ROAA)

23.00% (352.75%)

-9.10% (74.44%)

-35.60% (-53.45%)

-23.20% (36.44%)

Return on Sales (ROS)

26.90% (484.29%)

-7.00% (83.05%)

-41.30% (-19.36%)

-34.60% (45.60%)

Return on Invested Capital (ROIC)

75.00% (475.00%)

-20.00% (64.22%)

-55.90% (-58.81%)

-35.20% (52.69%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

13.39 (115.83%)

-84.62 (-612.25%)

-11.88 (46.55%)

-22.23 (25.57%)

Price to Sales Ratio (P/S)

3.17 (-55.03%)

7.06 (41.90%)

4.98 (-35.69%)

7.74 (-59.36%)

Price to Book Ratio (P/B)

4.17 (-65.00%)

11.91 (84.93%)

6.44 (-7.19%)

6.94 (-48.82%)

Debt to Equity Ratio (D/E)

0.62 (-15.51%)

0.73 (57.05%)

0.47 (59.18%)

0.29 (18.55%)

Earnings Per Share (EPS)

1.37 (470.27%)

-0.37 (72.39%)

-1.34 (-27.62%)

-1.05 (41.34%)

Sales Per Share (SPS)

5.78 (30.36%)

4.43 (38.61%)

3.2 (6.03%)

3.02 (7.44%)

Free Cash Flow Per Share (FCFPS)

0.95 (830.39%)

0.1 (114.47%)

-0.7 (10.76%)

-0.79 (13.57%)

Book Value Per Share (BVPS)

4.42 (67.75%)

2.64 (6.42%)

2.48 (-26.50%)

3.37 (-15.43%)

Tangible Assets Book Value Per Share (TABVPS)

6.45 (54.48%)

4.17 (14.74%)

3.64 (-16.64%)

4.36 (-12.18%)

Enterprise Value Over EBIT (EV/EBIT)

11 (111.00%)

-100 (-733.33%)

-12 (45.45%)

-22 (24.14%)

Enterprise Value Over EBITDA (EV/EBITDA)

10.69 (109.57%)

-111.79 (-856.44%)

-11.69 (48.27%)

-22.59 (22.31%)

Asset Turnover

0.97 (-10.15%)

1.08 (27.23%)

0.85 (27.54%)

0.67 (16.58%)

Current Ratio

2.38 (-1.94%)

2.42 (-40.07%)

4.04 (-37.13%)

6.43 (-5.04%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$157,196,000 (844.01%)

$16,652,000 (114.60%)

-$114,035,000 (10.05%)

-$126,782,000 (11.81%)

Enterprise Value (EV)

$2,929,793,200 (-42.38%)

$5,084,627,604 (105.76%)

$2,471,098,424 (-33.38%)

$3,709,311,363 (-54.13%)

Earnings Before Tax (EBT)

$258,075,000 (605.67%)

-$51,036,000 (76.09%)

-$213,444,000 (-27.41%)

-$167,519,000 (40.38%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$273,958,000 (702.32%)

-$45,484,000 (78.49%)

-$211,418,000 (-28.78%)

-$164,175,000 (40.95%)

Invested Capital

$386,782,000 (36.87%)

$282,585,000 (-28.33%)

$394,261,000 (-22.23%)

$506,975,000 (30.60%)

Working Capital

$543,448,000 (50.18%)

$361,871,000 (-5.35%)

$382,307,000 (-26.73%)

$521,755,000 (-14.70%)

Tangible Asset Value

$1,067,974,000 (56.26%)

$683,466,000 (16.27%)

$587,812,000 (-16.04%)

$700,122,000 (-10.41%)

Market Capitalization

$3,053,291,200 (-40.60%)

$5,140,487,604 (99.40%)

$2,577,941,424 (-31.29%)

$3,752,044,363 (-55.85%)

Average Equity

$572,679,250 (46.47%)

$390,995,000 (-8.31%)

$426,436,000 (-24.33%)

$563,573,250 (-12.73%)

Average Assets

$983,456,500 (46.81%)

$669,892,500 (10.39%)

$606,830,000 (-16.22%)

$724,349,250 (-6.09%)

Invested Capital Average

$344,084,750 (35.02%)

$254,832,250 (-33.24%)

$381,737,500 (-19.81%)

$476,055,750 (25.99%)

Shares

166,391,891 (1.35%)

164,180,377 (1.39%)

161,930,994 (0.73%)

160,755,971 (1.12%)